CoChat

Impact of Adaptive Servo-Ventilation on Cardiovascular Function and Prognosis in Heart Failure Patients with Preserved Left Ventricular Ejection Fraction and Sleep-Disordered Breathing

Yoshihisa, Akiomi, Suzuki, Satoshi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Nakazato, Kazuhiko, Suzuki, Hitoshi, Saitoh, Shu-ichi, Takeishi, Yasuchika · 2013 · European Journal of Heart Failure
Cited by 143

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims: Effective pharmacotherapy for heart failure with preserved left ventricular ejection fraction (HFpEF) is still unclear. Sleep-disordered breathing (SDB) causes cardiovascular dysfunction, giving rise to factors involved in HFpEF. However, it remains unclear whether adaptive servo-ventilation (ASV) improves cardiovascular function and long-term prognosis of patients with HFpEF and SDB. Methods and results: Thirty-six patients with HFpEF (LVEF >50%) and moderate to severe SDB (apnoea–hypopnoea index >15/h) were enrolled. Study subjects (LVEF 56.0%, apnoea–hypopnoea index 36.5/h) were randomly assigned to two groups: 18 patients treated with medications and ASV (ASV group) and 18 patients not treated with ASV (non-ASV group). NYHA class, cardiac function including LVEF, left atrial volume index (LAVI), E/E’, vascular function including flow-mediated dilatation (FMD) and cardio-ankle vascular index (CAVI), and levels of BNP and troponin T were determined at baseline and 6 months later. Patients were followed to register cardiac events after enrolment (follow-up 543 days). ASV therapy improved cardiac diastolic function and decreased CAVI and BNP (NYHA class, 2.3 to 1.5; LAVI, 48.6 to 42.6 mL/m2; E/E’, 12.8 to 7.1; CAVI, 9.0 to 7.7; BNP, 121.5 to 58.1 pg/mL, P < 0.0125, respectively). LVEF, FMD, and troponin T did not change significantly in either group. Importantly, the event-free rate was significantly higher in the ASV group than in the non-ASV group (94.4% vs. 61.1%, log-rank P < 0.05). Conclusion: ASV may improve the prognosis of HFpEF patients with SDB, with favourable effects such as improvement of symptoms, cardiac diastolic function, and arterial stiffness. ASV may be a useful therapeutic tool for HFpEF patients with SDB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs197

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 143

Metadata

Authors
Yoshihisa, A., Suzuki, S., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Suzuki, H., Saitoh, S.-I., & Takeishi, Y.
Venue
European Journal of Heart Failure
Published
2013-05-01
Volume
15
Issue
5
Pages
543-550
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2018694125
Cited by
143
References
3
FWCI
6.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Adaptive Servo-Ventilation on Cardiovascular Function and Prognosis in Heart Failure Patients with Preserved Left Ventricular Ejection Fraction and Sleep-Disordered Breathing. https://app.cochat.ai/papers/10.1093/eurjhf/hfs197
The paper
Yoshihisa, A., Suzuki, S., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Suzuki, H., Saitoh, S.-I., & Takeishi, Y. (2013). Impact of Adaptive Servo-Ventilation on Cardiovascular Function and Prognosis in Heart Failure Patients with Preserved Left Ventricular Ejection Fraction and Sleep-Disordered Breathing. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs197

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.